| Date | Title | Description |
| 09.04.2025 | The White House’s Cuts To Scientific Research Will Cut Short American Lives | Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from over-the-counter and prescription medications that treat high cholesterol and pain to protection from infectious diseases such... |
| 07.03.2025 | National Politics | White House doubles down on Trump’s claim about transgender mice | That list included $299,940 awarded by the National Cancer Institute in 2023 for a project examining breast cancer risk among transgender men. It involved comparing cancer rates among female mice and those receiving testosterone therapy.
An... |
| 24.02.2025 | Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI | Major finding provides mechanistic explanation for ibezapolstat's (IBZ) selectivity in that the predicted bactericidal interaction between IBZ and its target DNA pol IIIC is conserved across most of the Bacillota phylum, including C. diffic... |
| 18.02.2025 | New Insights into Peanut Allergy Treatment and Early Antibiotic Use in Children | In the world of allergies, new research is lighting the way. Two recent studies presented at the 2025 AAAAI / WAO Joint Congress in San Diego reveal critical insights into peanut allergies and the impact of early-life antibiotic exposure. T... |
| 18.02.2025 | Breaking Barriers: New Insights into Peanut Allergy Treatment and Childhood Skin Health | In the realm of allergies, two recent studies shed light on significant breakthroughs. One focuses on peanut allergies, a condition that can turn a simple snack into a life-threatening event. The other delves into the connection between nei... |
| 18.02.2025 | Breaking Barriers: New Hope for Allergy Sufferers | In the world of allergies, hope often feels like a distant star. But recent studies shine a light on innovative treatments that could change lives. Two groundbreaking research projects presented at the 2025 AAAAI/WAO Joint Congress reveal p... |
| 18.02.2025 | Breaking Barriers: New Insights into Allergy Treatments and Testing | In the world of allergies, new research is shining a light on two critical areas: peanut oral immunotherapy and the testing of penicillin allergies in hematopoietic stem cell transplant patients. These studies, presented at the 2025 AAAAI /... |
| 15.02.2025 | Peanut Oral Immunotherapy Using Store-Bought, Home-Measured Products is Effective for Children with High-Threshold Peanut Allergy | AAAAI
In this study, 100% of participants in the peanut oral immunotherapy group tolerated 9,043 mg of peanut product after treatment
MILWAUKEE, Feb. 15, 2025 /PRNewswire-PRWeb/ -- For children with high threshold peanut allergy, oral immun... |
| 20.01.2025 | National Politics | Biden pardons Fauci, Milley and the Jan. 6 committee in effort to guard against ‘revenge’ by Trump | Biden, a Democrat, has used the power in the broadest and most untested way possible: to pardon those who have not even been investigated. His decision lays the groundwork for an even more expansive use of pardons by Trump, a Republican, an... |
| 12.12.2024 | 1 факт — один лайк по биологии. Узнали? Погнали | Всем привет! С вами лоличка, звезда твиттера!
Я люблю усталых взрослых людей. Мне самой 41 год, и я сейчас работаю простым линейным оператором службы поддержки. Ранее мои статьи на Хабре удаляли постоянно, а сейчас хоть в научпоп разрешили ... |
| 21.11.2024 | Strengthening the Mid-Atlantic Region for Tomorrow Procurement Conference Attracts Key Defense Medical, Public Health, Infrastructure and Tech Leaders | SMART PROC 2024
SMART PROC is the premier small business procurement conference in Western Maryland, register today to hear from program and contracting offices on future requirements.
FREDERICK, Md., Nov. 21, 2024 /PRNewswire-PRWeb/ -- SMA... |
| 09.11.2024 | The Trump Administration's Immigration Strategy: A High-Stakes Game of State and Federal Dynamics | The immigration landscape in the United States is a battleground. The stakes are high, and the players are many. At the center of this conflict is former President Donald Trump, who is poised to re-enter the White House with a controversial... |
| 07.11.2024 | National Politics | Trump victory gives RFK Jr. free rein to shape public health | Trump has encouraged Kennedy, the son of the late U.S. attorney general and senator who was assassinated during his 1968 presidential campaign, to work on more specific issues.
“I said, ‘Bobby, you work on women’s health, you work on health... |
| 09.10.2024 | Innovations in Infection Control: PuraCath Medical and Endomimetics Lead the Charge | In the realm of healthcare, innovation is the lifeblood that keeps the industry thriving. Two recent breakthroughs from PuraCath Medical and Endomimetics showcase how technology can tackle pressing medical challenges. Both companies are on ... |
| 04.10.2024 | PuraCath Medical™ Demonstrates Significant Reduction of CLABSI-Associated Microorganisms in Needleless Connectors Using Novel UV Disinfection System | PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has published the result of its research on its ultraviol... |
| 16.09.2024 | Билл Гейтс рассказал обо всем: от успеха в Microsoft до возможных войн и пандемий | Когда Билл Гейтс бросил колледж, чтобы стать соучредителем Microsoft, он и не думал о том, что станет миллиардером. Но его энтузиазм и упорство привели к ошеломляющему успеху. Сейчас Гейтс увлечен биологией, физикой и климатологией. Эти тем... |
| 13.09.2024 | Albert Einstein College of Medicine Receives Major Federal Grant to Help Lead National Effort for Pandemic Preparedness | Einstein-Led Research Consortium Awarded Five-Year Grant for $14 M per Year
BRONX, N.Y., Sept. 13, 2024 /PRNewswire/ -- Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of ... |
| 14.08.2024 | Navigating the Digital Future: Africa's Youth and the Mpox Challenge | Africa stands at a crossroads. On one side, a vibrant youth population eager to harness the power of technology for sustainable development. On the other, a public health crisis threatening to derail progress. The continent's future hinges ... |
| 14.08.2024 | Africa public health body declares mpox emergency | Africa's top public health body declared what it termed a "public health emergency of continental security" on Tuesday (Aug 13) over an outbreak of mpox that has spread from the Democratic Republic of Congo to neighbouring countri... |
| 25.06.2024 | Bird flu survived pasteurization of heavily infected milk: study | Listen to the article 4 min
This audio is auto-generated. Please let us know if you have feedback.
In raw milk samples mixed with high levels of the bird flu, small amounts of the virus still remained after going through a standard pasteuri... |
| 25.06.2024 | Healcisio Receives Phase II STTR Funding to Continue Critical Care AI Research | Healcisio, a leader in AI and digital healthcare, announces it has received a $1 Million STTR Phase II award from the NIAID to advance the development of its critical care decision support platform and a new AI-powered software suite for ab... |
| 17.06.2024 | Overhaul threat: NIH faces Republican call for reorganization | figcaption>span]:font-sans" data-chromatic="ignore">
Congressional Republicans are calling for a reorganization of the National Institutes of Health that would strip its authority over "gain of function" resea... |
| 17.06.2024 | Bird flu virus outlasted pasteurization, study finds | figcaption>span]:font-sans" data-chromatic="ignore">
A small but detectable amount of H5N1 bird flu survived a standard pasteurization method on milk infected with high concentrations of the virus, National Institutes o... |
| 14.06.2024 | Infectious bird flu survived milk pasteurization in lab tests, study finds. Here's what to know. | A "small but detectable quantity" of infectious H5N1 bird flu virus was able to survive a common approach to pasteurizing milk, according to new research co-authored by scientists at the National Institutes of Health.
The findings... |
| 11.06.2024 | NIH hit for misrepresenting risky mpox research | figcaption>span]:font-sans" data-chromatic="ignore">
NIH misrepresented risky research on mpox — previously known as monkeypox — and denied that the work was proposed and approved when queried by Congress, a new House E... |
| 11.06.2024 | As FDA urges crackdown on bird flu in raw milk, some states say their hands are tied | Officials in two of the three states probing their first cases of bird flu in dairy cattle this month said their hands are tied after the Food and Drug Administration pleaded with states to ramp up testing and restrictions on potentially in... |
| 07.06.2024 | How AI Is Being Used to Revolutionize Mosquito Monitoring to Help Fight Malaria in Africa | By Jace Dela Cruz
Published Jun 7, 2024 11:29AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
Researchers at the University of South Florida are using artificial intelligence (AI... |
| 03.06.2024 | Fauci testifies about COVID pandemic response at heated House hearing | Washington — Dr. Anthony Fauci testified on Monday before a Republican-led House panel investigating the origins of COVID-19 and the government's pandemic response, in a widely anticipated hearing where the intense partisan divide over the ... |
| 23.05.2024 | Lyme Disease Epidemic: Wondercide Shares Why Tick Awareness is More Crucial Than Ever | An infected tick bite can result in the harsh side effects of Lyme disease for humans or pets.
Wondercide unveils the truth about ticks during Lyme Disease Awareness Month.
Lyme is personal in my family. One tiny tick can wreak havoc on any... |
| 20.05.2024 | Soligenix Encourages Stockholders to Vote Prior to Annual Meeting | Annual Meeting to be held May 23, 2024
PRINCETON, N.J., May 20, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to tre... |
| 17.05.2024 | NIAID Marks HIV Vaccine Awareness Day 2024 | Content From: NIAID Now•Published: May 17, 2024•5 min read
Topics Awareness DaysHIV Vaccine Awareness DayNIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of Health
Layout featuring a colorized 3D print of a... |
| 16.05.2024 | Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice | Published Results Confirm and Extend Response Results from Phase 3 FLASH Study
PRINCETON, N.J., May 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on develo... |
| 14.05.2024 | Resources for 2024 HIV Vaccine Awareness Day | Content From: HIV.gov•Published: May 14, 2024•2 min read
Topics Awareness DaysHIV Vaccine Awareness DayNIAIDNational Institute of Allergy & Infectious Diseases
Summary:
Resources to highlight HIV Vaccine Awareness Day on May 18, a day t... |
| 10.05.2024 | Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results | PRINCETON, N.J., May 10, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unme... |
| 01.05.2024 | TAXIS Pharmaceuticals Announces $2.67 Million NIH Grant to Advance Research and Development of Combination Therapy to Combat Antibiotic-Resistant Pneumonia | TAXIS Pharmaceuticals
TAXIS Pharmaceuticals' investigational efflux pump inhibitors have been shown to restore potency of FDA-approved antibiotics in animal studies.
NORTH BRUNSWICK, N.J., May 1, 2024 /PRNewswire-PRWeb/ -- TAXIS Pharmaceuti... |
| 24.04.2024 | U.S. orders cow testing for bird flu after grocery milk tests positive | The Agriculture Department is ordering the dairy industry to test milk-producing cows for infections from highly pathogenic avian influenza, or HPAI H5N1, before they're moved between states, federal officials announced Wednesday.
USDA's mo... |
| 17.04.2024 | Sexually Transmitted Infections—A Closer Look at NIAID Research | Content From: NIAID Newsroom•Published: April 17, 2024•4 min read
Topics NIAIDNational Institute of Allergy & Infectious DiseasesSTDsSexually Transmitted DiseasesSTI PlanFederal STI Action Plan
Electron micrograph imagery of bacteria th... |
| 17.04.2024 | Cygnus Consulting LLC Awarded SBA 8(a) Certification | Cygnus Consulting LLC is proud to announce its certification in the US Small Business Administration’s 8(a) Business Development Program as of April 1, 2024.
MCLEAN, VIRGINIA, USA, April 17, 2024 /EINPresswire.com/ -- Cygnus Consulting LLC ... |
| 09.04.2024 | NIH Ending the HIV Epidemic Projects Bridge Gaps Between HIV Research and Public Health Practice (VIDEO) | Content From: NIAID Now Blog•Published: April 09, 2024•5 min read
Topics EHEEnding the HIV Epidemic in the U.S. initiativeNIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of HealthResearch
The National Inst... |
| 25.03.2024 | Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB | AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures
CANBERRA, Australia, March 25, 2024 /PRNewswire/ -- The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million... |
| 12.03.2024 | Remdesivir (Veklury) Approval for the Treatment of COVID-19—The Evidence for Safety and Efficacy | Under FDA law, approval of a new drug requires substantial evidence of effectiveness and a demonstration of safety for the drug’s intended use(s). The approval of remdesivir (Veklury) for the treatment of patients hospitalized with COVID-19... |
| 12.03.2024 | Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results | SOUTH SAN FRANCISCO, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver ... |
| 08.03.2024 | HIV Treatment Research and Key Takeaways: Dr. Dieffenbach’s Final Update from CROI 2024 | Content From: HIV.gov•Published: March 08, 2024•5 min read
Topics CROIConference on Retroviruses & Opportunistic InfectionsNIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of HealthResearchTreatmentHIV ... |
| 04.03.2024 | Tools Underestimate Cardiovascular Event Risk in People with HIV | Content From: NIH Newsroom•Published: March 04, 2024•4 min read
Topics Cardiovascular HealthCROIConference on Retroviruses & Opportunistic InfectionsNIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of H... |
| 04.03.2024 | ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV | LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented the poster “Suppressing Asymptomatic CMV with Letermovir Reshapes Cardiometabolic Proteome ... |
| 22.02.2024 | Statement: Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed | Content From: NIAID Newsroom•Published: February 22, 2024•3 min read
Topics NIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of HealthResearchTreatmentHIV Treatment
Transmission electron micrograph of HIV-1... |
| 01.12.2023 | NIH Statement on World AIDS Day 2023 | Cross-posted from: NIH Newsroom
On this 35th World AIDS Day, the National Institutes of Health (NIH) joins its partners in honoring the lives lost due to the HIV pandemic. For decades, this virus has exacted a tragic toll, affecting people,... |
| 14.11.2023 | NIH Statement on Preliminary Efficacy Results of First-in-Class Gonorrhea Antibiotic Developed Through Public-Private Partnership | Content From: NIAID Newsroom•Published: November 14, 2023•3 min read
Topics NIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of HealthResearchSTDsSexually Transmitted DiseasesSTI PlanFederal STI Action Plan... |
| 23.08.2023 | SBIR supports startup innovations | According to Brian Walsh, Senior Technology Commercialization Manager at University of Wisconsin-Milwaukee Research Foundation (UWMRF), startups are a key source of technological innovations in the United States.
In his role, Walsh helps c... |
| 04.08.2023 | Valley fever is on the rise in the U.S., and climate change could be helping the fungus spread | Fears over valley fever are ramping up in Northern California Fears over valley fever are ramping up in Northern California 03:34
More than 500,000 Americans could be sickened each year by Valley fever, the disease caused by breathing in th... |
| 03.08.2023 | GSK Patent Suit Aims to Halt Pfizer’s RSV Vaccine for Adults, But Not Infants | The respiratory syncytial virus season is months away, but competition between the only two approved vaccines (so far) for the pathogen is already heating up. GSK is suing Pfizer, claiming that company’s vaccine infringes on four of its pat... |
| 25.06.2023 | People who preserve ‘immune resilience’ live longer, resist infections | Immune resilience explains why some people, regardless of age, have impact immune systems and reduced inflammation. The blue-clad spheres are T-cells. The lower sphere is COVID-19. Immune resilience is the capacity to maintain good immune f... |
| 21.06.2023 | ‘I’m Not Crazy, I’m Sick’: A film dives deep into chronic Lyme disease | Elle Brooks-Tao, a filmmaker, got thrust into the confusing world of Lyme disease when a family member became infected and had debilitating symptoms for over eight years before being diagnosed.
The reported cases of tick-borne illnesses lik... |
| 13.06.2023 | Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness | - |
| 08.06.2023 | Encouraging First-in-Human Results for a Promising HIV Vaccine | Cross-posted from: NIH Director’s Blog
Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D. Researchers used a customized nanoparticle (top left) to learn more about guiding the immune system to mount a desired robust response, the typ... |
| 25.05.2023 | CDC reports more mpox cases as authorities brace for summer resurgence | The Centers for Disease Control and Prevention this week tallied 21 more cases of mpox, the disease formerly called monkeypox, as authorities are now bracing for the possibility of a resurgence over the coming months.
Illinois makes up the ... |
| 24.05.2023 | Why does my butthole itch? 13 causes and how to remedy an itchy anus | Reviews Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options.
Health Why does my butthole itch? 13 causes and how to remedy an itchy anus
Written by Adam Barnes
Updated
2023-05-24T19:03:14... |
| 08.05.2023 | Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection | --Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far
--Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patient... |
| 14.04.2023 | Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds | Content From: NIAID Newsroom•Published: April 14, 2023•4 min read
Topics Cardiovascular HealthNIAIDNational Institute of Allergy & Infectious DiseasesNIHNational Institutes of HealthPeople with HIVResearch
Cross-posted from NIAID Newsro... |
| 14.04.2023 | Healthier Uses For The $5 Billion NextGen Covid-19 Funds | Paraphrasing a line miscredited to Einstein: “Insanity is repeating the same mistakes and expecting different results.” With the just announced White House $5 Billion Covid-19 NextGen Project for vaccine research and development, it seems t... |
| 15.02.2023 | While health authorities are racing to contain a deadly Marburg outbreak in Equatorial Guinea, the U.S. has experimental vaccines | The Biden administration may soon deploy experimental doses of vaccine to a new outbreak of Marburg virus, officials told an "urgent" meeting convened by the World Health Organization this week, as health authorities are racing to... |
| 31.01.2023 | Ascletis Announces U.S. FDA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection | --Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far
--Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patient... |
| 16.12.2022 | Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories | Image
Caption Attendees participate in this annual training course where they learn best practices for ensuring data quality and integrity in BSL-4 facilities.
Current course | Background | Course description | 2019 highlights | FAQs | Scie... |
| 13.12.2022 | Health
Health | Grillo Center: Specific treatment not needed for most RSV cases | By Sue Smith
Grillo Center
Q: I’ve heard that RSV infections are prevalent right now. Can you tell me more about this virus?
A: RSV stands for respiratory syncytial virus, a common seasonal respiratory infection that occurs primarily in the... |
| 02.12.2022 | 20 years ago, a Lyme-disease vaccine was taken off the market. Now, 2 companies are developing one that could be available by 2025. | Some kinds of Borrelia bacteria, illustrated here, can cause Lyme disease. KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty Images
A Lyme-disease vaccine candidate produced antibodies that lasted at least six months.
The vaccine is being created by... |
| 25.11.2022 | XBB variant's arrival won't cause a new deadly COVID surge, officials hope | The Centers for Disease Control and Prevention revealed Friday it is now tracking a new COVID-19 variant of concern around the U.S. known as XBB, which has grown to make up an estimated 3.1% of new infections nationwide.
The strain's preval... |
| 21.10.2022 | As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine | Maybe you’ve never heard of the Epstein-Barr virus. But it knows all about you.
Chances are, it’s living inside you right now. About 95% of American adults are infected sometime in their lives. And once infected, the virus stays ... |
| 19.10.2022 | NIH probes whether Boston University COVID experiments should have triggered review | Boston University refutes report that lab created dangerous COVID strain
Boston University refutes report that lab created dangerous COVID strain 03:02
The National Institutes of Health is now examining whether experiments performed at Bost... |
| 12.09.2022 | CDC warns about enterovirus in kids — and the risk of rare paralysis that can follow | After virtually disappearing for several years amid measures aimed at curbing the spread of COVID-19, the Centers for Disease Control and Prevention is now urging doctors to be vigilant for a renewed wave of enterovirus D68, or EV-D68 — a v... |
| 29.08.2022 | Grid Biosciences Announces License Agreement with NIH for Epstein-Barr Virus Vaccine | NEW YORK (PRWEB) August 29, 2022
Grid Biosciences (“Grid”), a biotechnology company, today announced the signing of a license agreement for the development of a vaccine against Epstein-Barr virus (“EBV”) with the National Institute of Aller... |
| 22.08.2022 | Anthony Fauci says he's stepping down in December for "next chapter" of career | Washington — Dr. Anthony Fauci, the nation's preeminent infectious disease expert who has served under seven presidents, said Monday that he will step down from his post in December to pursue the "next chapter" of his career.
&quo... |
| 11.08.2022 | Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex for Control of Cytomega... | MIAMI, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic produc... |
| 04.08.2022 | Monoclonal Antibody Might Help Prevent Malaria | THURSDAY, Aug. 4, 2022 (HealthDay News) -- Researchers are reporting early but encouraging findings on a potential new way to prevent malaria — an old foe that still ranks as a major killer worldwide.
In a small trial of healthy volunteers,... |
| 19.07.2022 | Monkeypox: What we know about the outbreak, vaccinations and treatments | Health officials around the world are racing to curb an outbreak of monkeypox cases that has swelled into the thousands, deploying both vaccines and treatments for a disease that can lead to weeks of painful rashes and lesions for those inf... |
| 15.07.2022 | As Big Pharma loses interest in new antibiotics, infections are only growing stronger | Forget Covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even h... |
| 08.02.2022 | 3 Ways Artificial Intelligence Can be Used to Improve Health Equity | John Sargent | Founding Partner, BroadReach Group
When I graduated from medical school and took the Hippocratic Oath, I vowed to not just treat the illness on a patient’s medical history form but to treat the person behind the diagnosis. To... |
| 01.02.2022 | Novavax could offer unvaccinated Americans a new option, if regulators agree | Following a long-awaited submission of data to the Food and Drug Administration last month, Novavax announced Monday that it had formally filed a request for emergency use authorization of its protein-based COVID-19 vaccine in the United St... |
| 28.01.2022 | The CDC’s director says she and Fauci are ‘easy targets’ for pandemic anger and frustration: ‘People want somebody to blame’ | CDC Director Rochelle Walensky sat down for an exclusive interview with Insider, one year into her new job.
She called the pandemic a “natural disaster,” but says we “can use science to try and cope” and improve the situation.
But “many peo... |
| 28.01.2022 | The World’s First Women’s Age Lab And Why We Need It: Covid-19, Sex And Death | Dr. Paula Rochon, Founding Director of the Women's Age LabWomen's College Hospital |
| 28.11.2021 | Fauci Raises Concerns And Red Flags About Future Of Covid Crisis | WASHINGTON, DC - JULY 20: Top infectious disease expert Dr. Anthony Fauci responds to accusations by ... [+] Sen. Rand Paul, R-Ky., as he testifies before the Senate Health, Education, Labor, and Pensions Committee, July 20, 2021 on Capitol... |
| 27.10.2021 | Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines | TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) So... |
| 20.10.2021 | Dr. Anthony Fauci Received Big Pay Increase To Prevent Pandemics | WASHINGTON, DC - APRIL 08: Dr. Anthony Fauci, director of the National Institute of Allergy and ... [+] Infectious Diseases, attends the daily coronavirus task force briefing in the Brady Press Briefing Room at the White House on April 08, ... |
| 12.10.2021 | 23andMe : Tackling Tough Problems with the 23andMe Therapeutics Team | Kipper Fletez-Brant, a computational biologist with our Therapeutics division, thought he'd be a physicist one day.
Growing up in Phoenix, Arizona, Kipper escaped the heat reading "hard-sci-fi novels" with mind-bending plots woven... |
| 29.09.2021 | VBI Vaccines : Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern (Form 8-K) | VBI Vaccines Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern
- New preclinical data demonstrate VBI-2905 induced robust neutralizing and antibody... |
| 28.09.2021 | NIH spotlights trio of academic teams chasing after 'pan-coronavirus' vaccines | Having made loud and clear its call for new research on vaccines that can tackle future pandemics, the NIH is shedding light on some of the projects it’s funding.
The National Institute of Allergy and Infectious Diseases (N... |
| 22.06.2021 | 3 Houston innovators make Forbes list of up-and-coming entrepreneurs | Three Houston entrepreneurs are basking in the national spotlight.
The trio — Vernee Hines, Carolyn Rodz, and Siddhartha Sachdeva — were just named to Forbes' Next 1000 list of the country's up-and-coming entrepreneurs. They're among the 25... |
| 22.06.2021 | 2 Houston research projects unveil groundbreaking solar and battery technologies | Research, perhaps now more than ever, is crucial to expanding and growing innovation in Houston — and it's happening across the city right under our noses.
In InnovationMap's latest roundup of research news, two Houston institutions are wor... |
| 16.06.2021 | Splashy European pool-sharing app dives into Houston just in time for summer | Scorching temps. Baking cars. ERCOT begging locals to set their thermostats to 78 (say what?). Why, it's almost like it's summer in Houston or something.
After a long sweat, nothing cools off like a long swim in a sparkling pool. To that en... |
| 16.06.2021 | New Houston startup development program to help launch corporate volunteer software | Brooke Waupsh wanted to change the way people volunteered and help increase access to volunteers for nonprofits. So, she launched Swoovy, a dating app that connected singles who wanted to do some good on their first dates. Now, the Austin-b... |
| 16.06.2021 | Houston researchers snag government funds for net-zero emissions projects | Rice University and the University of Houston were two of four national institutions to receive sizable grants from the Department of Energy last month to go toward the research and development of projects that will improve CO2 storage to h... |
| 01.06.2021 | NIH National Institutes of Health : launches clinical trial of universal influenza vaccine candidate | News Release
Tuesday, June 1, 2021 NIH launches clinical trial of universal influenza vaccine candidate
Computer-generated image of nanoparticle influenza vaccine.NIAID
A first-in-human, Phase 1 trial assessing the safety and immunogenicity... |
| 20.05.2021 | Restore a better balance to public-private funding of biomedical research | The pharmaceutical industry says that if the U.S. reduces the astronomical drug prices paid by U.S. consumers, lifesaving innovation will be devastated.
That’s not true. There are ways for the U.S. to reduce drug prices while maintaining an... |
| 05.05.2021 | Houston health tech company bounces back from COVID-19 in a big way | The pandemic hit life science innovation hard. And no one knows that better than Kevin Coker, co-founder and CEO of Proxima Clinical Research, a Houston-based contract research organization focused on supporting life science startups as the... |
| 04.05.2021 | Report: Houston ranks among the worst cities for unnecessary medical treatments | Houston boasts of being home to the Texas Medical Center, the world's biggest medical complex. Yet Houston's medical community also holds a distinction that's hardly boast-worthy: It's the worst major metro area in Texas for unnecessary hea... |
| 04.05.2021 | Expert shares advice for Houstonians experiencing a pandemic-sparked career change | I've had so many pivots in my professional career; moving across the country, internal promotions, leaving a corporate job to launch my own company, and repositioning myself and my brand in new markets. But I'm one of those people who enjoy... |
| 28.04.2021 | Houston startup selected for international carbontech accelerator | A new international accelerator focused on the commercialization of carbontech has announced its new cohort — and one Houston-based company has made the cut.
Cemvita Factory has been accepted into the Carbon to Value Initiative, a recently ... |
| 28.04.2021 | VBI VACCINES INC.
VBI Vaccines : Announces Publication of Preclinical and Challenge Study Data of its eVLP Vaccine Candidate Against COVID-19 (VBI-2902) | VBI Vaccines Announces Publication of Preclinical and Challenge Study Data of its eVLP Vaccine Candidate Against COVID-19 (VBI-2902)
- Publication title : 'An enveloped virus-like particle vaccine expressing a stabilized prefusion form of t... |
| 28.04.2021 | Houston investor goes all in on funding female founders | Carrie Colbert wasn't planning on becoming a venture capital investor — it just happened organically.
"This has been kind of a backwards process. Our fund was driven by demand," Colbert, founder and general partner of Houston-base... |
| 27.04.2021 | EY makes the case for people and culture amid historical oil and gas disruption | When considering the future of energy, you might see a world powered by cleaner energy sources and guided by bots and algorithms in the workplace. But digitalization and decarbonization are complex transitions. The road ahead will mix human... |
| 22.04.2021 | Texas expert: Energy reliability and climate sustainability are not mutually exclusive | It's no secret that Texas has long been a leader in energy production, but it may surprise you to learn that Texas leads the nation in wind-powered generation, producing 28 percent of all US wind-powered electricity in 2019.
We're not just ... |
